Raymond James Financial’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.3M Buy
1,194,625
+11,694
+1% +$221K 0.01% 1427
2025
Q4
$22.4M Sell
1,182,931
-2,999
-0.3% -$56.6K 0.01% 1362
2025
Q3
$21.9M Sell
1,185,930
-113,714
-9% -$1.86M 0.01% 1355
2025
Q2
$20.1M Buy
1,299,644
+110,011
+9% +$1.7M 0.01% 1366
2025
Q1
$19.3M Buy
1,189,633
+251,977
+27% +$4.33M 0.01% 1337
2024
Q4
$15M Buy
+937,656
New +$16.6M 0.01% 1513

Other funds holding HQH

Raymond James Financial's HQH Position: Q1 2026 in Review

Raymond James Financial increased its abrdn Healthcare Investors (HQH) stake by 0.99% in Q1 2026, buying an estimated $221K and bringing the position to 1,194,625 shares worth $21.3M. The position accounts for 0.01% of the portfolio, ranked #1427.

Raymond James Financial first reported a position in HQH in Q4 2024 and has held it in 6 quarters since. The position peaked at $22.4M in Q4 2025. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.

  • Raymond James Financial held 1,194,625 shares of abrdn Healthcare Investors worth $21.3M as of Q1 2026.
  • Raymond James Financial bought 11,694 abrdn Healthcare Investors shares in Q1 2026, an estimated $221K.
  • abrdn Healthcare Investors made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1427 holding.
  • Raymond James Financial first reported a position in abrdn Healthcare Investors in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's abrdn Healthcare Investors position peaked at $22.4M in Q4 2025.
  • 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.